Metabolic and cardiovascular benefits of GLP-1 agonists, besides the hypoglycemic effect (Review)

Patients with type 2 diabetes exhibit higher cardiovascular risk than normal individuals. Optimal blood glucose levels are rarely achieved in diabetic patients. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have emerged as a new antidiabetic drug class with multiple metabolic effects. Some t...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Exp Ther Med
Prif Awduron: Iorga, Roua Anamaria, Bacalbasa, Nicolae, Carsote, Mara, Bratu, Ovidiu Gabriel, Stanescu, Ana Maria Alexandra, Bungau, Simona, Pantis, Carmen, Diaconu, Camelia Cristina
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: D.A. Spandidos 2020
Pynciau:
Review
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7401476/
https://ncbi.nlm.nih.gov/pubmed/32765722
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2020.8714
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg